The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FOLFIRI followed by radiochemotherapy and surgery in locally advanced gastric cancer: FFCD 0308 phase II trial.
P. Michel
No relevant relationships to disclose
G. Breysacher
No relevant relationships to disclose
F. Desseigne
No relevant relationships to disclose
L. Dahan
No relevant relationships to disclose
C. Petorin
No relevant relationships to disclose
D. Moussata
No relevant relationships to disclose
J. Grenier
No relevant relationships to disclose
S. Nguyen
No relevant relationships to disclose
F. Viret
No relevant relationships to disclose
N. Carrere
No relevant relationships to disclose
C. Mariette
No relevant relationships to disclose
C. Garnier Tixidre
No relevant relationships to disclose
K. Bouhier Leporrier
No relevant relationships to disclose
M. Galais
No relevant relationships to disclose
F. Fein
No relevant relationships to disclose
I. Iwanicki- Caron
No relevant relationships to disclose
E. Maillard
No relevant relationships to disclose
B. Dousset
No relevant relationships to disclose
F. Mornex
No relevant relationships to disclose
L. Bedenne
No relevant relationships to disclose